Delivery Order SPE2DR25D3004-SPE2DR26FXLT7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $1,818.93. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires completion by November 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors with a firm fixed price ceiling value of $5,463.56 and an ultimate completion date of November 12, 2025. This is a non-set-aside, competitively awarded delivery order utilizing firm fixed pricing. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $2,372.39. This is a firm fixed-price delivery order with an ultimate completion date of November 4, 2025, and represents a non-set-aside competitive award. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $2,907.40. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The order is set for completion by November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $5,066.85. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, representing a non-set-aside award issued through competitive procedures. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $2,026.98. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $3,156.24. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,076.73 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to support federal medical procurement needs. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $4,564.98. This firm fixed-price delivery order, with an ultimate completion date of October 28, 2025, represents a small-value pharmaceutical transaction supporting federal medical procurement needs. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $1,218.01, with completion scheduled for August 22, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical transaction within the broader federal medical supply chain. The contract specifies performance at AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXLT7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors at a firm fixed price ceiling of $2,907.40. This non-set-aside delivery order, with an ultimate completion date of November 14, 2025, represents a continuation of pharmaceutical supply support under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime indefinite delivery contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply diverse pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's substantial federal contract portfolio demonstrates established capability in fulfilling competitive federal medical procurement requirements across a wide spectrum of therapeutic domains, including specialty medications, vaccines, and medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/13/25 |